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SCHEME OF INTERMITTENT FASTING AND REDUCTION OF
ANTHROPOMETRIC MEASURES, LIPID PROFILE, BLOOD
PRESSURE AND CARDIOVASCULAR RISK
ESQUEMA DE AYUNO INTERMITENTE Y REDUCCIÓN DE MEDIDAS ANTROPOMÉTRICAS, PERFIL LIPÍDICO,
PRESIÓN ARTERIAL Y RIESGO CARDIOVASCULAR
J. Javier Wong-Gonzales1, José Antonio Quispe-Palacios1

ABSTRACT
Introduction: Lifestyle is a fundamental role in the risk of cardiovascular diseases and chronic diseases.
Objective: To evaluate the eﬀect of the 16/8 intermittent fasting scheme against anthropometric
measurements, lipid pro le values, blood pressure and cardiovascular risk. Method: Longitudinal analytical
study with intervention. Fifteen patients treated in the nutrition area in a private center between January and
October 2020 submitted to the 16/8 intermittent fasting scheme for four months, seeking to reduce
anthropometric measurements, lipid pro le, blood pressure and / or cardiovascular risk. Variables: body
weight, body mass index (BMI), waist-hip index (WHI), abdominal circumference, lipid pro le, cardiovascular
risk according to Framingham (Framingham AMR B table), total cholesterol / HDL and LDL / HDL indices.
Results: The average age was 47.1 years, the average height was 1.66 m., The average body weight was 84.3
Kg., The average of the BMI was 30.46, the average of the WHI was 0.94, the average of the abdominal
circumference was 99.87, the mean total cholesterol, HDL and LDL were 240.06, 43.73 and 153.2 respectively,
the mean cardiovascular risk according to Framingham was 0.11% and the mean total cholesterol / HDL and
LDL / HDL indices were 5.88 and 3.69. The evaluation of averages before and after found signi cant
diﬀerences (p <0.05) at 3 and 4 months of evaluation. Conclusions: The intermittent fasting scheme showed a
signi cant reduction in anthropometric measurements, lipid pro le and cardiovascular risk. Additionally, an
increase in HDL was observed.
Keywords: Intermittent fasting, body weight, body mass index, blood pressure, lipid pro le.

RESUMEN
Introducción: El estilo de vida juega un rol fundamental en el riesgo de enfermedades cardiovasculares y
enfermedades crónicas. Objetivo: Evaluar el efecto del esquema de ayuno intermitente 16/8 frente a las
medidas antropométricas, valores de per l lipídico, presión arterial y riesgo cardiovascular. Métodologia:
Estudio analítico longitudinal con intervención. Quince pacientes tratados en el área de nutrición en un
centro privado entre enero y octubre del 2020 sometidos al esquema de ayuno intermitente 16/8 por cuatro
meses, buscando la reducción de medidas antropométricas, per l lipídico, presión arterial y/o riesgo
cardiovascular. Variables: peso corporal, índice de masa corporal (IMC), índice cintura – cadera (ICC),
circunferencia abdominal, per l lipídico, riesgo cardiovascular según Framingham (tabla de Framingham
AMR B), índices colesterol total/HDL y LDL/HDL. Resultados: La edad promedio fue 47.1 años, la talla
promedio fue 1.66 m., el peso corporal promedio fue 84.3 Kg., el promedio del IMC fue 30.46, el promedio del
ICC fue 0.94, el promedio de la circunferencia abdominal fue 99.87, el promedio del colesterol total, HDL y LDL
fue 240.06, 43.73 y 153.2 respectivamente, el promedio del riesgo cardiovascular según Framingham fue
0.11% y el promedio de los índices colesterol total/HDL y LDL/HDL fue 5.88 y 3.69. La evaluación de
promedios antes y después encontró diferencias signi cativas (p<0.05) a los 3 y 4 meses de evaluación.
Conclusiones: El esquema de ayuno intermitente mostró reducción signi cativa de las medidas
antropométricas, per l lipídico y riesgo cardiovascular. Adicionalmente se observó aumento del HDL.
Palabras claves: Ayuno intermitente, peso corporal, índice de masa corporal, presión arterial, per l lipídico.
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INTRODUCTION
Intermittent fasting or intermittent food restriction
(RAI), as it is also known, is a lifestyle approach applied
to individuals whose objective is mainly the regulation
of body weight(1) . The evidence shows that the practice
of RAI has favorable repercussions on health; not only
because of the progressive weight loss, but also
because of the consequence it has on the muscular
system (2) . That is to say, it implies a bene t on the
metabolism. Some authors aﬃrm that this practice also
has a positive eﬀect on other health conditions,
including the value of blood pressure, lipid pro le and
muscle mass index (BMI).
Harmful habits, unhealthy eating, sedentary lifestyle,
insuﬃcient sleep, among others, will lead to obesity,
high blood pressure, dyslipidemia; all of them will lead
to an increase in cardiovascular risk and, therefore, the
propensity to suﬀer a cardiovascular event(3,4) .
According to the WHO, in 2011, there were around 17
million individuals who died from some cardiovascular
disease (29.82%) and it was estimated that for the
present (2020) this number would increase by 15 to
20%. Also, it was predicted that by 2030 around 23.6
million individuals will die; this being the main cause of
death worldwide (5) .
In Peru, after a study conducted in which cardiovascular
risks versus risk factors were addressed in a hospital in
Lima, it was found that a large percentage of the
individuals evaluated suﬀered from obesity and / or
diabetes mellitus; both are metabolic disorders that
lead to increased cardiovascular risk (6) .
Due to the aforementioned, the objective of this study is
to evaluate the eﬀect of the 16/8 intermittent fasting
scheme against anthropometric measurements, lipid
pro le values and cardiovascular risk.

METHODS
Design and study area
An analytical, longitudinal study with intervention was
used in patients attending the nutrition area of a private
health center in metropolitan Lima, Peru.

Population and sample
After a previous explanation of the intervention,
patients treated i n a nutrition area clinic in a private
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health center, who had not obtained adequate results
with traditional nutrition methods prior to the tests,
were invited to perform the 16/8 intermittent fasting
scheme after prior explanation of the intervention.
months of January and October 2020, of which fteen
patients agreed to participate for 4 months.
The recommendation was given by a quali ed
nutritionist, who, in turn, prescribed a dietary structure
for each of the patients according to his requirements;
that is, whether the patient was seeking weight
reduction, lipid pro le reduction, blood pressure
reduction or increase in muscle mass. Those patients
younger than 20 years and older than 70 or patients
with chronic renal failure (CRF) were excluded; as well as
those who decided not to participate in the scheme.

Variables and instruments
The variables considered in the study are smoking,
weight, body mass index, waist-hip index (ICC),
abdominal circumference, lipid pro le, in which the
values of HDL, LDL and total cholesterol, systolic blood
pressure ( SBP) and diastolic blood pressure (DBP),
cardiovascular risk obtained as a percentage from the
Framingham AMR B risk table, which is a variant of the
Framingham table that is applied in the Latino
population. The risk index for coronary heart disease
(I.R.E.C) was also used, which includes I.R.E.C * (total
cholesterol / HDL cholesterol index) and I.

Criteria evaluated in the Framingham AMR B
table
Age
Diabetes
Smoking habit
Total cholesterol
HDL cholesterol
Systolic blood pressure (SBP) by sex
Diastolic blood pressure (DBP) by sex
All participants had an exhaustive evaluation of
anthropometric measurements using a calibrated
mechanical scale from the nutrition oﬃce to obtain the
patient's weight. There was also a height rod
incorporated into the scale to obtain the patient's
height. With the two previous values, the BMI was
obtained. The waist-hip index was found after
obtaining the perimeter of the waist using a tape
measure; as well as the size of the hip circumference.
The abdominal circumference was also obtained by
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using a tape measure according to the WHO

Additionally, the p value of each variable was found by

recommendations. The lipid pro le, where the values of

means of the Student's t statistical test for means of

HDL, LDL and total cholesterol were obtained, was
measured through a biochemical examination with

paired samples provided by the Excel program; as well

enzymatic and colorimetric techniques within the

as the Chi square statistical test to compare prevalences

facilities of the private center. The blood pressure of

of the diﬀerent parameters evaluated before and after

each of the patients was measured through the

the program.

repeated use of an analog sphygmomanometer and
stethoscope.

Ethical issues
The fteen patients underwent the 16/8 intermittent

Both the author and co-authors state that they have no

fasting scheme for four months. The measurement of
the previously mentioned variables was carried out

con icts of interest after conducting this study. The

once the study period had ended. The follow-up of each

study respects the privacy and con dentiality of the

of the patients was monthly or bimonthly according to

personal data of each of the participants.

the request of the nutritionist. Due to the state of
emergency, part of the follow-up was carried out
through teleconferences in which the patient had to

The

Declaration of Helsinki guidelines for research in
humans were met.

report her weight at that time; as well as, the waist, hip
and abdominal circumference.

RESULTS

Additionally, it was considered if the participant used

Prior to performing the 16/8 intermittent fasting

tobacco at the beginning of the scheme, if he suﬀered

scheme, the mean and standard deviation obtained

from any comorbidity or if he was medicated with some

from the fteen participants were: for age it was 47.1

type of drug.
years ± 11.4; for height it was 1.66 meters ± 0.10; for
Carrying out this particular intermittent fasting scheme

initial body weight it was 84.3 ± 17.6 Kg; for BMI it was

consists of 16 hours of uninterrupted fasting and 8

30.4 ± 5.14 Kg / m2; ICC was 0.9 ± 0.05; for abdominal

hours where the participant is allowed to eat food
according to the type of diet that the nutritionist has

circumference it was 99.8 ± 10.6; for total cholesterol,

determined; the latter could be hypocaloric,

HDL and LDL were 240.0 ± 42.8, 43.7 ± 10.6 and 153.2 ±

normocaloric or hyperproteic.

43.8 respectively. For cardiovascular risk according to

Statistical analysis

Framingham it was 12.0% ± 0.09 and total cholesterol /

The eﬀect of the 16/8 scheme of intermittent fasting on

HDL and LDL / HDL indices of 5.88 ± 2.16 and 3.6 ± 1.3

the previously mentioned variables was evaluated

respectively. In addition, it was established whether or

using the nding of the arithmetic mean or sample

not the participant was a smoker; the type of diet

mean in each of the variables considered. Likewise, the
absolute value was found; as well as, the proportion of
variation between the initial data and nal data.

recommended; as well as whether or not they had
diabetes mellitus (Table 1).
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Table 1. General characteristics of the patients.
Frequency

Percentage

8
7
47.1

53.3
46.7
± 11.4

2
13
1.66

13.3
86.7
± 0.10

2
13

13.3
86.7

2
10
4

12.5
62.5
25

Sex
Male
Feminine
Age*
Smoker
Yes
No
Size
Diabetes mellitus 2
Yes
NoT
ype of diet **
Normocaloric
Hypocaloric
Hyperprotein

* Mean and standard deviation
** The count is greater than 15, since one patient had a hypocaloric
and hyperprotein diet

After the intervention, the results obtained were: for

5.14 vs. 27.7 ± 4.8; the evaluation of the other

body weight, 84.3 ± 17.6 vs. 76.8 ± 15.9; for BMI, 30.4 ±

parameters is presented in Table 2.

Table 2. The mean and standard deviation of the anthropometric parameters and blood
pressure are shown before and after the intervention.

Weight
BMI
Abdominal circumference
Waist-hip ratio
Systolic blood pressure
Diastolic blood pressure

Before
84.3 ± 17.6
30.4 ± 5.14
99.8 ± 10.6
0.9 ± 0.05
149.3 ± 18.2
83.6± 7.1

After
76.8 ± 15.9
27.7 ± 4.8
92.1 ± 8.6
0.8 ± 0.05
128.0 ± 13.7
74.0 ± 6.3

P value
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001

The results for lipid pro le are shown in Table 3; as well

according according to the Framingham table and the

as the results of the cardiovascular risk obtained

risk indices for coronary heart disease.
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Table 3. Before and after parameters of lipid pro

le, cardiovascular risk and risk
indices for coronary heart disease.

HDL cholesterol
LDL cholesterol
Total cholesterol
According to Framingham ***
IREC * for combined sexes
High
Under
IREC ** for combined sexes
High
Under

Before
After
43.7 ± 10.6
52.1 ± 11.2
153.2 ± 43.8 113.7 ± 33.9
240.0 ± 42.8 166.1 ± 35.0
12.0% ± 0.094 4% ± 0.03

P value
< 0.001
< 0.001
< 0.001
< 0.001

10 (66.7%)
5 (33.3%)

0 (0%)
15 (100%)

0.007

9 (60%)
6 (40%)

0 (0%)
15 (100%)

0.012

Fig. 1 The median (in orange), the maximum value (in blue) and the minimum value (in yellow) are placed. A.
Weight before and after the intervention. B. body mass index before and after the intervention. C. Abdominal
circumference before the intervention and after the intervention. D. Waist-to-hip ratio before the intervention
and after the intervention.
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Fig. 2 Se coloca la mediana (en naranja), el valor máximo (en azul) y el valor mínimo (en amarillo). A. Presión arterial
sistólica antes de la intervención y después de la intervención. B. Presión arterial diastólica antes de la intervención y
después de la intervención. C. Colesterol total antes de la intervención y después de la intervención. D. Colesterol HDL
antes de la intervención y después de la intervención. E. Colesterol LDL antes de la intervención y después de la
intervención.

Fig. 3 The median (in orange), the maximum value (in blue) and the minimum value (in yellow) are placed.
A. Cardiovascular risk according to Framingham before the intervention and after the intervention. B. I.R.E.C
* (Total cholesterol / HDL index) before the intervention and after the intervention. C. I.R.E.C ** (LDL / HDL
Index) before the intervention and after the intervention.
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DISCUSSION
The presentation of these series of clinical cases
indicated that the 16/8 intermittent fasting scheme has
an impact on the factors evaluated such as weight, BMI,
CHF, abdominal circumference, T-c, HDL-c, LDL-c, R.C.
and I.R.E.C. in a variable way in each of the participants,
the latter is related to the type of diet carried out. It is
very important to highlight that, although in all
reported cases a reduction in cardiac risk has been seen,
in the case of one of the participants this decrease is
much more noticeable (31% vs. 10%), this is probably
due to the marked reduction in both your systolic and
diastolic blood pressure; as well as, the decrease in total
cholesterol.
Regarding the I.R.E.C., in most of the participants a
reduction of the indices was found for both c-T / c-HDL;
as well as for LDL-C / HDL-C; Likewise, authors such as
Camelo et al (7) ., Peterson (8) , Malinowski et al (9) . Haiyan(10) ,
demonstrated through their studies the reduction of
the values within the lipid pro le. The latter is also a risk
factor for contracting cardiovascular disease. Therefore,
the application of some intermittent fasting scheme
would help to reduce the values within said pro le; and,
consequently, the reduction of the risk of some
cardiovascular event.
In relation to body weight and BMI, the fteen
participants presented a reduction in these values, the
most striking case being in one of them (92 Kg vs 78.9
Kg.) And (30.04 Kg / m2 vs 25.75 Kg / m2), which In
addition to the 16/8 intermittent fasting scheme, he
consumed a hypocaloric and hyperprotein diet.
When conducting an exhaustive review, it was found
that authors such as Rosa Fernandez et al (11) ., Harris et
al (12) ., Johnstone (13) . , Tinsley and La Bounty (14) ., Antoni et
al (15) ., among others, demonstrate in their studies the
impact from intermittent fasting versus the ght
against overweight and obesity; which today have
become a worldwide evil, being one of the main causes
of contracting cardiovascular disease. His studies
showed that intermittent fasting is a good method to
reduce the weight of the individual; However, it must
consider the eﬀort that this practice entails; since it has
been shown that during the rst weeks the adaptation
process will be complicated and is the main cause of
abandonment of this approach to lifestyle.
Regarding the evaluation of CHF and the measurement
of the abdominal circumference, all the participants
showed reduction; However, the reduction in CHF was

much more marked in one of them (1.5 vs. 0.97) and that
of abdominal circumference, in another (115.6 vs. 97.8);
the latter consumed a hypocaloric diet. This reduction
could in turn be related to the decrease in coronary risk.
Authors such as Mukai et al (16) ., Ahmet et al (17) .,
Ramasamy et al (18) . highlighted the bene ts obtained in
their studies on the heart.
During the evaluation of systolic and diastolic blood
pressure, a reduction was observed in most of the
participants, which, at the time of their evaluation,
could be classi ed as arterial hypertension; or
maintenance of blood pressures when the participant
was in the normal range. In two of the participants, a
signi cant reduction in SBP was observed (150 mmHg
vs. 110 mmHg) (170 mmHg vs. 130 mmHg), respectively.
Tinsley and Horne 19) ., Mattson et al (20) . evidenced the
impact on blood pressure, demonstrating its reduction
during their study.
When assessing the lipid pro le, in the fteen
participants it was possible to see a reduction on the c-T
values. Regarding LDL-C, 14 of the participants showed
a reduction in values. Authors such as Meng et al10
point out that intermittent fasting is eﬀective for
controlling the lipid pro le; however, he emphasizes
that in relation to HDL it does not show a signi cant
eﬀect, but suggests that a further study be carried out.
Some aspects that require special attention of this
approach within lifestyle medicine could be the
diﬃculties and peculiarities of its application; that is to
say, its application may not be adjusted to the reality of
all patients; therefore, there must be very clear selection
criteria for patients who are candidates for this
approach; for example, those who suﬀer from severe
hypertension, kidney disease, high LDL levels, high uric
acid levels, and type 1 diabetes mellitus may have
contraindications; which does not occur in individuals
with type 2 diabetes mellitus (21) .
It is important to emphasize, then, that the bene ts of
intermittent fasting on the cardiovascular system are
varied and with its application many of the patients who
are within the risk group, with the exception of those
previously mentioned, would nd a possibility of
improvement in his life style.
The main limitations were the diﬃculty in data
collection and mobilization to obtain them, because
during the time interval taken to carry out the study, it
combined with the world situation due to COVID-19.
Furthermore, the adjustment for type of diet is not
being considered and there is no group for comparison.
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CONCLUSION
Although the application of intermittent fasting as a

reduction in anthropometric measurements, lipid

contingency plan against cardiovascular diseases

pro le and blood pressure, and cardiovascular risk.

requires many more studies. It is concluded that the

Additionally, an increase in HDL-cholesterol was

intermittent fasting scheme showed a signi cant

observed in the sample studied.
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